𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Everolimus: A New Treatment Option for Advanced Pancreatic Neuroendocrine Tumors

✍ Scribed by Thompson, L. A.; Kim, M.; Wenger, S. D.; O'Bryant, C. L.

Book ID
118057739
Publisher
Harvey Whitney Books Company
Year
2012
Tongue
English
Weight
155 KB
Volume
46
Category
Article
ISSN
1060-0280

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Everolimus for Advanced Pancreatic Neuro
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
✍ Yao, James C.; Shah, Manisha H.; Ito, Tetsuhide; Bohas, Catherine Lombard; Wolin πŸ“‚ Article πŸ“… 2011 πŸ› Massachusetts Medical Society 🌐 English βš– 667 KB

## Background: Everolimus, an oral inhibitor of mammalian target of rapamycin (mtor), has shown antitumor activity in patients with advanced pancreatic neuroendocrine tumors, in two phase 2 studies. we evaluated the agent in a prospective, randomized, phase 3 study. ## Methods: We randomly assign